Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 50 , ISSUE 2 ( April-June, 2016 ) > List of Articles

RESEARCH ARTICLE

Clinical experience with oral topotecan in relapsed small cell lung cancer patients following irinotecan-platinum chemotherapy

Digambar Behera, Navneet Singh, Venkata Nagarjuna Maturu, Inderpaul Singh Sehgal

Citation Information : Behera D, Singh N, Maturu VN, Sehgal IS. Clinical experience with oral topotecan in relapsed small cell lung cancer patients following irinotecan-platinum chemotherapy. J Postgrad Med Edu Res 2016; 50 (2):110-111.

DOI: 10.5005/jpmer-50-2-110

License: CC BY-ND 4.0

Published Online: 01-06-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 2006 Dec 1;24(34):5441-5447.
  2. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. J Clin Oncol 2007 May 20;25(15): 2086-2092.
  3. Management of advanced lung cancer in resource-constrained settings: a perspective from India. Expert Rev Anticancer Ther 2012 Nov;12(11):1479-1495.
  4. Tumor cavitation among lung cancer patients receiving firstline chemotherapy at a tertiary care centre in India: association with histology and overall survival. Med Oncol 2013; 30(3):602
  5. Intercycle delays during chemotherapy of non-small cell lung cancer in a health care resource-constrained setting and their effect on overall survival. J Thorac Oncol 2010 Feb;5(2):236-239.
  6. Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer. Cancer Chemother Pharmacol 2008 Nov;62(6):1009-1014.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.